“Novel Substituted 5-Arylidene-1, 3-Thiazolidin-4-One Analogues: Synthesis, Optimization, Anticancer Screening and Docking Studies”. Journal of Pharmaceutical Negative Results, Oct. 2022, pp. 2378-89, https://doi.org/10.47750/pnr.2022.13.S06.310.